BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
BusinessProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10By Nasdaq OMXMay 31, 2017, 11:08 AM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC
BusinessARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXMay 15, 2017, 12:32 PM UTC